Sep
20,
2020
Feluda-The New Low Cost Covid 19 Test by TATA CRISPR. The Drugs Controller General of India (DCGI)
has approved the commercial launch of ‘Feluda’, the Tata CRISPR (Clustered
Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of
Scientific and Industrial Research (CSIR) said on 19 Sep 2020.
This test uses an indigenously...